Luana Gilio - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Luana Gilio

Showing results (41-50 of 50) with videos related to

Pageof 5

Sort By:

You have reached the last page of results.This site can display upto 50 results.

Multiple Sclerosis (Houndmills, Basingstoke, England)|June 5, 2019

Obesity worsens central inflammation and disability in multiple sclerosisMario Stampanoni Bassi, Ennio Iezzi, Fabio Buttari, et al.

Journal of Neuroinflammation|May 14, 2024

Interleukin-9 protects from microglia- and TNF-mediated synaptotoxicity in experimental multiple sclerosisLivia Guadalupi, Valentina Vanni, Sara Balletta, et al.

International Journal of Molecular Sciences|May 25, 2024

Interaction between miR-142-3p and <i>BDNF</i> Val/Met Polymorphism Regulates Multiple Sclerosis SeverityEttore Dolcetti, Alessandra Musella, Sara Balletta, et al.

Current Neuropharmacology|April 6, 2023

MiR-142-3p is a Critical Modulator of TNF-mediated Neuronal Toxicity in Multiple SclerosisFrancesca De Vito, Sara Balletta, Silvia Caioli, et al.

Frontiers in Molecular Neuroscience|August 22, 2024

Interleukin-10 contrasts inflammatory synaptopathy and central neurodegenerative damage in multiple sclerosisLuana Gilio, Diego Fresegna, Mario Stampanoni Bassi, et al.

Frontiers in Immunology|June 24, 2024

Re-emergence of T lymphocyte-mediated synaptopathy in progressive multiple sclerosisKrizia Sanna, Antonio Bruno, Sara Balletta, et al.

Neurobiology of Disease|July 14, 2022

Preventive exercise attenuates IL-2-driven mood disorders in multiple sclerosisLuana Gilio, Diego Fresegna, Antonietta Gentile, et al.

Cells|February 10, 2021

The microRNA let-7b-5p Is Negatively Associated with Inflammation and Disease Severity in Multiple SclerosisGeorgia Mandolesi, Francesca Romana Rizzo, Sara Balletta, et al.

Neuropathology and Applied Neurobiology|September 7, 2021

MiR-142-3p regulates synaptopathy-driven disease progression in multiple sclerosisFrancesca De Vito, Alessandra Musella, Diego Fresegna, et al.

Brain, Behavior, and Immunity|March 4, 2026

Physical exercise modulates T cell activity and mitigates synaptic dysfunction in multiple sclerosis through vagus nerve engagementAlessandra Musella, Sara Balletta, Claudia Russo, et al.

Pageof 5

Search research articles

Showing results (41-50 of 50) with videos related to

Sort By:

Pageof 5

You have reached the last page of results.This site can display upto 50 results.

Multiple Sclerosis (Houndmills, Basingstoke, England)|June 5, 2019

Obesity worsens central inflammation and disability in multiple sclerosisMario Stampanoni Bassi, Ennio Iezzi, Fabio Buttari, et al.

Journal of Neuroinflammation|May 14, 2024

Interleukin-9 protects from microglia- and TNF-mediated synaptotoxicity in experimental multiple sclerosisLivia Guadalupi, Valentina Vanni, Sara Balletta, et al.

International Journal of Molecular Sciences|May 25, 2024

Interaction between miR-142-3p and <i>BDNF</i> Val/Met Polymorphism Regulates Multiple Sclerosis SeverityEttore Dolcetti, Alessandra Musella, Sara Balletta, et al.

Current Neuropharmacology|April 6, 2023

MiR-142-3p is a Critical Modulator of TNF-mediated Neuronal Toxicity in Multiple SclerosisFrancesca De Vito, Sara Balletta, Silvia Caioli, et al.

Frontiers in Molecular Neuroscience|August 22, 2024

Interleukin-10 contrasts inflammatory synaptopathy and central neurodegenerative damage in multiple sclerosisLuana Gilio, Diego Fresegna, Mario Stampanoni Bassi, et al.

Frontiers in Immunology|June 24, 2024

Re-emergence of T lymphocyte-mediated synaptopathy in progressive multiple sclerosisKrizia Sanna, Antonio Bruno, Sara Balletta, et al.

Neurobiology of Disease|July 14, 2022

Preventive exercise attenuates IL-2-driven mood disorders in multiple sclerosisLuana Gilio, Diego Fresegna, Antonietta Gentile, et al.

Cells|February 10, 2021

The microRNA let-7b-5p Is Negatively Associated with Inflammation and Disease Severity in Multiple SclerosisGeorgia Mandolesi, Francesca Romana Rizzo, Sara Balletta, et al.

Neuropathology and Applied Neurobiology|September 7, 2021

MiR-142-3p regulates synaptopathy-driven disease progression in multiple sclerosisFrancesca De Vito, Alessandra Musella, Diego Fresegna, et al.

Brain, Behavior, and Immunity|March 4, 2026

Physical exercise modulates T cell activity and mitigates synaptic dysfunction in multiple sclerosis through vagus nerve engagementAlessandra Musella, Sara Balletta, Claudia Russo, et al.

Pageof 5